GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictmedix AI Inc (XCNQ:PMED) » Definitions » YoY EBITDA Growth

Predictmedix AI (XCNQ:PMED) YoY EBITDA Growth : 75.00% (As of Jul. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Predictmedix AI YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Predictmedix AI's YoY EBITDA Growth for the quarter that ended in Jul. 2024 was 75.00%.

Predictmedix AI's EBITDA per Share for the three months ended in Jul. 2024 was C$-0.00.

Predictmedix AI YoY EBITDA Growth Historical Data

The historical data trend for Predictmedix AI's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictmedix AI YoY EBITDA Growth Chart

Predictmedix AI Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
YoY EBITDA Growth
- - -137.50 10.53 -

Predictmedix AI Quarterly Data
Jan19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Jul23 Oct23 Jul24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -40.00 -66.67 - 75.00

Predictmedix AI YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Predictmedix AI's YoY EBITDA Growth for the fiscal year that ended in Jan. 2023 is calculated as:

YoY EBITDA Growth (A: Jan. 2023 )
=(EBITDA per Share (A: Jan. 2023 )-EBITDA per Share (A: Jan. 2022 ))/ | EBITDA per Share (A: Jan. 2022 ) |
=(-0.017--0.017)/ | -0.017 |
=0.00 %

Predictmedix AI's YoY EBITDA Growth for the quarter that ended in Jul. 2024 is calculated as:

YoY EBITDA Growth (Q: Jul. 2024 )
=(EBITDA per Share (Q: Jul. 2024 )-EBITDA per Share (Q: Oct. 2022 )) / | EBITDA per Share (Q: Oct. 2022 )) |
=(-0.001--0.004)/ | -0.004 |
=75.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Predictmedix AI YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Predictmedix AI's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Predictmedix AI Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictmedix AI Inc (XCNQ:PMED) » Definitions » YoY EBITDA Growth
Comparable Companies
TSXV:EVMT TSXV:NGMD TSXV:ZCT XCNQ:MYTC TSXV:FREQ XCNQ:ASTI TSXV:IDL TSXV:CHIP.H TSXV:THRM TSXV:MDX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
PMEDF:USA 3QP0:Germany
Address
77 King Street West, Suite 3000, Toronto, ON, CAN, M5K 1G8
Website
https://www.predictmedix.com
Predictmedix AI Inc provides rapid health screening and remote patient care solutions globally. The company's Safe Entry Stations are powered by a proprietary artificial intelligence (AI) that uses multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses.

Predictmedix AI Headlines

No Headlines